Genzyme Corporation Faces FDA Enforcement Action Published: Mar 24, 2010 Boston Business Journal -- Genzyme Corporation will likely face financial penalties as part of an enforcement action from the U.S. Food and Drug Administration announced Wednesday. Related links Forbes This will open in a new window The Business Journals This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news